China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Expression of G3BP1 in breast cancer patients and its impact on the efficacy of neoadjuvant therapy'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135604
Registration Time: 2026/10/30
Type: Observational study
Primary Sponsor: The Second Hospital of Anhui Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349676
Published by HT Digital Content Services with permission from Health Daily Digest....